These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16377001

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
    Sajic D, Ashkar AA, Patrick AJ, McCluskie MJ, Davis HL, Levine KL, Holl R, Rosenthal KL.
    J Med Virol; 2003 Dec; 71(4):561-8. PubMed ID: 14556270
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA.
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
    Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, Rosenthal KL.
    J Infect Dis; 2004 Nov 15; 190(10):1841-9. PubMed ID: 15499542
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
    Tengvall S, Harandi AM.
    J Reprod Immunol; 2008 Jun 15; 78(1):49-57. PubMed ID: 17945349
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
    Barrier M, Lacroix-Lamandé S, Mancassola R, Auray G, Bernardet N, Chaussé AM, Uematsu S, Akira S, Laurent F.
    J Infect Dis; 2006 May 15; 193(10):1400-7. PubMed ID: 16619188
    [Abstract] [Full Text] [Related]

  • 11. The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges.
    Harandi AM.
    J Clin Virol; 2004 Jul 15; 30(3):207-10. PubMed ID: 15135735
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides.
    Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA.
    Adv Drug Deliv Rev; 2009 Mar 28; 61(3):226-32. PubMed ID: 19162103
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes.
    Tengvall S, Lundqvist A, Eisenberg RJ, Cohen GH, Harandi AM.
    J Virol; 2006 Jun 28; 80(11):5283-91. PubMed ID: 16699008
    [Abstract] [Full Text] [Related]

  • 19. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.
    Ashkar AA, Bauer S, Mitchell WJ, Vieira J, Rosenthal KL.
    J Virol; 2003 Aug 28; 77(16):8948-56. PubMed ID: 12885911
    [Abstract] [Full Text] [Related]

  • 20. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 28; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.